DASH vs EBS
DoorDash, Inc. Class A Common Stock (DASH) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. EBS currently screens at market cap $416.4M.
Not investment advice. Open the DASH and EBS stock pages for the full models.
Not investment advice.